Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination

Journal of Neuroimmunology

Volumn 283, Issue , 2015, Pages 58-62

  van der Heide, Astrid ^a   Hegeman Kleinn, Ingrid M ^a   Peeters, Els ^b   Lammers, Gert J ^a,c   Fronczek, Rolf ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

Autoimmune; Cataplexy; Hypothalamus; Immunohistochemistry; Narcolepsy type 1

Indexed keywords

AUTOANTIBODY; INFLUENZA VACCINE; OREXIN A; AUTOANTIGEN; NERVE PROTEIN; NEUROPEPTIDE; OREXINS; SIGNAL PEPTIDE;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MALE; MIDDLE AGED; NARCOLEPSY; NARCOLEPSY TYPE 1; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; YOUNG ADULT; BLOOD; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; HYPOTHALAMUS; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; MAMMILLARY BODY; NERVE CELL; ONSET AGE; VACCINATION;

ADOLESCENT; AGE OF ONSET; AUTOANTIBODIES; AUTOANTIGENS; CHILD; CHILD, PRESCHOOL; HUMANS; HYPOTHALAMUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMILLARY BODIES; MIDDLE AGED; NARCOLEPSY; NERVE TISSUE PROTEINS; NEURONS; NEUROPEPTIDES; VACCINATION; YOUNG ADULT;

EID: 84929587567     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.04.008     Document Type: Article

References (37)

1. American Academy of Sleep Medicine International Classification of Sleep Disorders - Third Edition (ICSD-3) 2014, (Darien, Illinois).
2. Aran A., Lin L., Nevsimalova S., Plazzi G., Hong S.C., Weiner Lachmi K., Zeitzer J., Mignot E. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009, 32:979-983.
3. Bergman P., Adori C., Vas S., Kai-Larsen Y., Sarkanen T., Cederlund A., Agerberth B., Julkunen I., Horvath B., Kostyalik D., Kalmár L., Bagdy G., Huutoniemi A., Partinen M., Hökfelt T. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc. Natl. Acad. Sci. 2014, 111:E3735-E3744.
4. Cvetkovic-Lopes V., Bayer L., Dorsaz S., Maret S., Pradervand S., Dauvilliers Y., Lecendreux M., Lammers G.-J., Donjacour C.E.H.M., Du Pasquier R.A., Pfister C., Petit B., Hor H., Mühlethaler M., Tafti M. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J. Clin. Invest. 2010, 120:713-719. 10.1172/JCI41366DS1.
5. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., Sakurai T., Yanagisawa M., Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:748-753.
6. Dauvilliers Y., Bauer J., Rigau V., Lalloyer N., Labauge P., Carlander B., Liblau R., Peyron C., Lassmann H. Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy. JAMA Neurol. 2013, 70:1305-1310.
7. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:322-327.
8. Elias C.F., Saper C.B., Maratos-Flier E., Tritos N.A., Lee C., Kelly J., Tatro J.B., Hoffman G.E., Ollmann M.M., Barsh G.S., Sakurai T., Yanagisawa M., Elmquist J.K. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 1998, 402:442-459.
9. Faraco J., Lin L., Kornum B.R., Kenny E.E., Trynka G., Einen M., Rico T.J., Lichtner P., Dauvilliers Y., Arnulf I., Lecendreux M., Javidi S., Geisler P., Mayer G., Pizza F., Poli F., Plazzi G., Overeem S., Lammers G.J., Kemlink D., Sonka K., Nevsimalova S., Rouleau G., Desautels A., Montplaisir J., Frauscher B., Ehrmann L., Hogl B., Jennum P., Bourgin P., Peraita-Adrados R., Iranzo A., Bassetti C., Chen W.M., Concannon P., Thompson S.D., Damotte V., Fontaine B., Breban M., Gieger C., Klopp N., Deloukas P., Wijmenga C., Hallmayer J., Onengut-Gumuscu S., Rich S.S., Winkelmann J., Mignot E. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet. 2013, 9:e1003270.
10. Fontana A., Gast H., Reith W., Recher M., Birchler T., Bassetti C.L. Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?. Brain 2010, 133:1300-1311.
11. Fredrikson S., Carlander B., Billiard M., Link H. CSF immune variables in patients with narcolepsy. Acta Neurol. Scand. 1990, 81:253-254.
12. Hallmayer J., Faraco J., Lin L., Hesselson S., Winkelmann J., Kawashima M., Mayer G., Plazzi G., Nevsimalova S., Bourgin P., Hong S.-C., Hong S.S.-C., Honda Y., Honda M., Högl B., Longstreth W.T., Montplaisir J., Kemlink D., Einen M., Chen J., Musone S.L., Akana M., Miyagawa T., Duan J., Desautels A., Erhardt C., Hesla P.E., Poli F., Frauscher B., Jeong J.-H., Lee S.-P., Ton T.G.N., Kvale M., Kolesar L., Dobrovolna M., Nepom G.T., Salomon D., Wichmann H.-E., Rouleau G.A., Gieger C., Levinson D.F., Gejman P.V., Meitinger T., Young T., Peppard P., Tokunaga K., Kwok P.-Y., Risch N., Mignot E. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Genet. 2009, 41:708-711.
13. Han F., Lin L., Warby S.C., Faraco J., Li J., Dong S.X., An P., Zhao L., Wang L.H., Li Q.Y., Yan H., Gao Z.C., Yuan Y., Strohl K.P., Mignot E. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann. Neurol. 2011, 70:410-417.
14. Han F., Faraco J., Dong X.S., Ollila H.M., Lin L., Li J., An P., Wang S., Jiang K.W., Gao Z.C., Zhao L., Yan H., Liu Y.N., Li Q.H., Zhang X.Z., Hu Y., Wang J.Y., Lu Y.H., Lu C.J., Zhou W., Hallmayer J., Huang Y.-S., Strohl K.P., Pollmächer T., Mignot E. Genome wide analysis of narcolepsy in china implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet. 2013, 9:e1003880. 10.1371/journal.pgen.1003880.
15. Kawashima M., Lin L., Tanaka S., Jennum P., Knudsen S., Nevsimalova S., Plazzi G., Mignot E. Anti-Tribbles Homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep 2010, 33:869-874.
16. Knudsen S., Mikkelsen J.D., Jennum P. Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons. Neuroreport 2007, 18:77-79.
17. Koepsell T.D., Longstreth W.T.J., Ton T.G.N. Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people. J. Sleep Res. 2010, 19:80-86.
18. Kornum B.R., Kawashima M., Faraco J., Lin L., Rico T.J., Hesselson S., Axtell R.C., Kuipers H., Weiner K., Hamacher A., Kassack M.U., Han F., Knudsen S., Li J., Dong X., Winkelmann J., Plazzi G., Nevsimalova S., Hong S.-C., Honda Y., Honda M., Högl B., Ton T.G.N., Montplaisir J., Bourgin P., Kemlink D., Huang Y.-S., Warby S., Einen M., Eshragh J.L., Miyagawa T., Desautels A., Ruppert E., Hesla P.E., Poli F., Pizza F., Frauscher B., Jeong J.-H., Lee S.-P., Strohl K.P., Longstreth W.T., Kvale M., Dobrovolna M., Ohayon M.M., Nepom G.T., Wichmann H.-E., Rouleau G.A., Gieger C., Levinson D.F., Gejman P.V., Meitinger T., Peppard P., Young T., Jennum P., Steinman L., Tokunaga K., Kwok P.-Y., Risch N., Hallmayer J., Mignot E. Common variants in P2RY11 are associated with narcolepsy. Nat. Genet. 2010, 43:66-71. 10.1038/ng.734.
19. Lim A.S.P., Scammell T.E. The trouble with Tribbles: do antibodies against TRIB2 cause narcolepsy?. Sleep 2010, 33:857-858.
20. Luca G., Haba-Rubio J., Dauvilliers Y., Lammers G.-J., Overeem S., Donjacour C.E., Mayer G., Javidi S., Iranzo A., Santamaria J., Peraita-Adrados R., Hor H., Kutalik Z., Plazzi G., Poli F., Pizza F., Arnulf I., Lecendreux M., Bassetti C., Mathis J., Heinzer R., Jennum P., Knudsen S., Geisler P., Wierzbicka A., Feketeova E., Pfister C., Khatami R., Baumann C., Tafti M., European Narcolepsy Network (EU-NN) Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J. Sleep Res. 2013, 22:482-495. 10.1111/jsr.12044.
21. Martínez-Rodríguez J.E., Sabater L., Graus F., Iranzo A., Santamaria J. Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy. Sleep 2007, 30:27-28.
22. Mignot E., Hayduk R., Black J., Grumet F.C., Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997, 20:1012-1020.
23. Mignot E., Lammers G.J., Ripley B., Okun M., Nevsimalova S., Overeem S., Vankova J., Black J., Harsh J., Bassetti C., Schrader H., Nishino S. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol. 2002, 59:1553-1562.
24. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 1999, 827:243-260.
25. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355:39-40.
26. Nohynek H., Jokinen J., Partinen M., Vaarala O., Kirjavainen T., Sundman J., Himanen S.L., Hublin C., Julkunen I., Olsen P., Saarenpaa-Heikkila O., Kilpi T. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012, 7:e33536.
27. Overeem S., Verschuuren J.J., Fronczek R., Schreurs L., den H.H., Hegeman-Kleinn I.M., van Duinen S.G., Unmehopa U.A., Swaab D.F., Lammers G.J. Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy. J. Neuroimmunol. 2006, 174:187-191.
28. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18:9996-10015.
29. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., Nishino S., Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 2000, 6:991-997.
30. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
31. Schuld A., Uhr M., Pollmächer T. Oligoclonal bands and specific antibody indices in human narcolepsy. Somnologie 2004, 71-74.
32. Tabuchi S., Tsunematsu T., Black S.W., Tominaga M., Maruyama M., Takagi K., Minokoshi Y., Sakurai T., Kilduff T.S., Yamanaka A. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function. J. Neurosci. 2014, 34:6495-6509. 10.1523/JNEUROSCI.0073-14.2014.
33. Tafti M., Hor H., Dauvilliers Y., Lammers G.J., Overeem S., Mayer G., Javidi S., Iranzo A., Santamaria J., Peraita-Adrados R., Vicario J.L., Arnulf I., Plazzi G., Bayard S., Poli F., Pizza F., Geisler P., Wierzbicka A., Bassetti C.L., Mathis J., Lecendreux M., Donjacour C.E.H.M., van der Heide A., Heinzer R., Haba-Rubio J., Feketeova E., Högl B., Frauscher B., Benetó A., Khatami R., Cañellas F., Pfister C., Scholz S., Billiard M., Baumann C.R., Ercilla G., Verduijn W., Claas F.H.J., Dubois V., Nowak J., Eberhard H.-P., Pradervand S., Hor C.N., Testi M., Tiercy J.-M., Kutalik Z. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 2014, 37:19-25.
34. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27:469-474.
35. Thannickal T.C., Siegel J.M., Nienhuis R., Moore R.Y. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol. 2003, 13:340-351.
36. Toyoda H., Tanaka S., Miyagawa T., Honda Y., Tokunaga K., Honda M. Anti-Tribbles Homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep 2010, 875-878.
37. Wijnans L., Lecomte C., de Vries C., Weibel D., Sammon C., Hviid A., Svanström H., Mølgaard-Nielsen D., Heijbel H., Dahlström L.A., Hallgren J., Sparen P., Jennum P., Mosseveld M., Schuemie M., van der Maas N., Partinen M., Romio S., Trotta F., Santuccio C., Menna A., Plazzi G., Moghadam K.K., Ferro S., Lammers G.-J., Overeem S., Johansen K., Kramarz P., Bonhoeffer J., Sturkenboom M.C.J.M. The incidence of narcolepsy in Europe: before, during, and after the influenza A (H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013, 31:1246-1254.